Agepha Pharma

Agepha Pharma We supply classic, safe, and affordable drugs that have been trusted by thousands of happy customers since 1947. We care about building trust through honesty.

We care about improving quality of our customers' lives. We're here to help, because we care.

AGEPHA Pharma was pleased to attend The Royal College of Ophthalmologists (RCOphth) Annual Congress 2026 in Manchester.T...
25/05/2026

AGEPHA Pharma was pleased to attend The Royal College of Ophthalmologists (RCOphth) Annual Congress 2026 in Manchester.

The congress provided an excellent opportunity to showcase our expanding ophthalmic portfolio and engage with ophthalmologists on the latest developments in ophthalmic patient care and treatment solutions.

We would like to thank everyone who visited our stand and contributed to the valuable discussions throughout the event.

AGEPHA Pharma is at 100% Optical at the Excel London from February 28th to March 2nd! Come say hello at Booth M02 and di...
26/02/2026

AGEPHA Pharma is at 100% Optical at the Excel London from February 28th to March 2nd!

Come say hello at Booth M02 and discover our eye care range designed to support healthier, more comfortable vision.

We look forward to meeting you there!

Last week, AGEPHA Pharma attended The Pharmacy Show in , where we had the pleasure of meeting and healthcare professi...
21/10/2025

Last week, AGEPHA Pharma attended The Pharmacy Show in , where we had the pleasure of meeting and healthcare professionals from across the United Kingdom.

We showcased our product range, introduced exciting new additions, and exchanged valuable insights on advancing patient care.

Thank you to everyone who stopped by to connect with us!

AGEPHA Pharma is at The Pharmacy Show at NEC Birmingham from October 12–13!Come say hello at Booth A80 and discover our ...
12/10/2025

AGEPHA Pharma is at The Pharmacy Show at NEC Birmingham from October 12–13!

Come say hello at Booth A80 and discover our eye care range designed to support healthier, more comfortable vision.

We look forward to meeting you there!

The AGEPHA Pharma team was pleased to attend the at the Bella Center in Copenhagen.We had the opportunity to showcase ...
17/09/2025

The AGEPHA Pharma team was pleased to attend the at the Bella Center in Copenhagen.

We had the opportunity to showcase our ophthalmic portfolio and connect with clinicians from Europe, discussing the evolving needs in eye care and our treatment options.

Thank you to everyone who visited our booth, we look forward to meeting you again next year!

AGEPHA Pharma will be attending at the Bella Center in from September 12–16.You can find us in Hall C, Booth C.1059,...
12/09/2025

AGEPHA Pharma will be attending at the Bella Center in from September 12–16.

You can find us in Hall C, Booth C.1059, where we will be showcasing our ophthalmic range.

We look forward to engaging with healthcare professionals at this leading ophthalmology congress.

Heading to ?Join in Boston|MA|August 1–3.Stop by our booth to learn how LODOCO® (colchicine 0.5 mg) is helping reduce...
31/07/2025

Heading to ?

Join in Boston|MA|August 1–3.

Stop by our booth to learn how LODOCO® (colchicine 0.5 mg) is helping reduce cardiovascular risk in patients—by targeting residual CV .

For more information 🔗 lodoco.com

We look forward to seeing you there!

More Than Lipids – It’s Time to Treat CVD InflammationThe EKSTROM trial confirms it: Colchicine 0.5 mg daily slows coron...
04/07/2025

More Than Lipids – It’s Time to Treat CVD Inflammation

The EKSTROM trial confirms it: Colchicine 0.5 mg daily slows coronary plaque progression in patients with stable CAD.

Prescribing colchicine 0.5 mg:
➡️ Targets residual
➡️ Supports plaque stabilization
➡️ Works synergistically with statin therapy
➡️ Easy once-daily regimen

Learn more: https://bit.ly/4kmU7Kq

Low-Dose Colchicine is no longer only approved for gout. It’s now changing the landscape of care.
01/07/2025

Low-Dose Colchicine is no longer only approved for gout. It’s now changing the landscape of care.

updateDaily colchicine 0.5 mg slowed artery hardening (calcified plaque) and showed early shrinkage of soft, rupture-p...
26/06/2025

update
Daily colchicine 0.5 mg slowed artery hardening (calcified plaque) and showed early shrinkage of soft, rupture-prone plaque in stable .

Read more: Learn more: https://bit.ly/4kmU7Kq

Adresse

Copenhagen

Internet side

Underretninger

Vær den første til at vide, og lad os sende dig en email, når Agepha Pharma sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Genveje

Del

Type